Clinical Trial Update: Anticoagulation for Aortic Bioprosthesis (ANTIPRO) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on anticoagulation for patients with aortic valve bioprostheses completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Aortic Valve Insufficiency
• Aortic Valve Regurgitation
• Aortic Valve Stenosis

Snippet

Sponsor: Instituto Nacional de Cirugia Cardiaca, Uruguay | Conditions: Aortic Valve Stenosis, Aortic Valve Disease | Phase 4 | Status: COMPLETED